Skip to main content
. 2022 Nov 3;14(21):5416. doi: 10.3390/cancers14215416

Figure 2.

Figure 2

Organoids as tool to dissect intratumor heterogeneity. Generating organoids from various regions of an individual tumor enables to interrogate subclones for differences in the genome, epigenome, and transcriptome. The clonal organoids can also be tested for their sensitivity towards various drugs or drug combinations, therefore serving as surrogate system for personalized medicine.